New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management

New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management

Abstract Pharmacological and cellular treatment of cancer is changing dramatically with benefits for patient outcome and comfort, but also with new toxicity profiles. The majority of adverse events can be classified as mild or moderate, but severe and life-threatening complications requiring ICU adm...

Full description

Bibliographic Details
Main Authors: Frank Kroschinsky, Friedrich Stölzel, Simone von Bonin, Gernot Beutel, Matthias Kochanek, Michael Kiehl, Peter Schellongowski, on behalf of the Intensive Care in Hematological and Oncological Patients (iCHOP) Collaborative Group
Format: Article
Language:English
Published: BMC 2017-04-01
Series:Critical Care
Subjects:
Cancer
Targeted therapy
Immunotherapy
Toxicity
Interdisciplinary management
Online Access:http://link.springer.com/article/10.1186/s13054-017-1678-1

Internet

http://link.springer.com/article/10.1186/s13054-017-1678-1

Similar Items